Dr. Dr.Web

Products

The main products developed and supplied by Doctor Web:

• To protect workstations and file servers running Windows
• for protection of corporate network and national-scale networks with centralized control of anti-virus protection;
• ^[1] service ^[2] for ISP;
• to protect mail and file servers under UNIX systems;
• to protect Internet gateways under UNIX systems;
• to protect file servers running Novell NetWare;
• to protect Lotus Domino servers on the Microsoft Windows platform;
• To protect Microsoft Exchange servers
• to protect Windows Mobile PDAs.

• Dr.Web Enterprise Security Suite is certified in accordance with the requirements for anti-virus protection tools (Order of the FSTEC of Russia dated 20.03.2012 No. 28) for the Protection Profiles of anti-virus protection tools of type "A," "B," "C" and "D" of the second class of protection.
• Dr.Web fully complies with the requirements of the Law "On Personal Data"

Performance indicators

2021: Revenue growth by 5.5% to RUB 1,146 million

At the end of 2021, Doctor Web's revenue amounted to 1,146 million rubles, an increase of 5.5% compared to 2020, which allowed it to take 195th place in the ranking of TAdviser100: The largest IT companies in Russia 2022. The revenue from the financial statements for 2020-2021 is indicated. excluding VAT.

History

2022: Exchange of data on cyber threats with Rostelecom-Solar

Rostelecom-Solar and Dr.Web have entered into an agreement to jointly counter computer attacks. Companies will share analytics and statistics on current cyber threats, as well as detected indicators of compromise (IOC). The partnership also involves the exchange of experience within working groups. Such interaction will help both companies more efficiently and quickly identify computer attacks and eliminate their consequences. Rostelecom-Solar announced this on March 16, 2022. Read more here.

2020: Revenue - RUR 1,086 million

At the end of 2020, Doctor Web's revenue amounted to 1,086 million rubles.

2017: Hit by Ukrainian sanctions

On May 16, 2017, President of Ukraine Petro Poroshenko, by his decree, enacted the decision of the National Security and Defense Council (NSDC) on sanctions against Russian companies and their subsidiaries in Ukraine. In total, 468 legal entities were on the sanctions list, of which 81 were related to the IT sphere. Among the companies that fell under the sanctions was also Dr.Web. Read more here.

2010

In December 2010, it became known that Dr.Web had acquired a representative office in Japan. It was Doctor Web Pacific, a 100% subsidiary of Dr.Web, headquartered in Kawasaki. Xu Sugawara, "well known among the information security specialists of the Land of the Rising Sun," has been appointed head of the Japanese office.

The Pacific representative office will focus on large corporate clients, the company said. Although the company indicates that Dr.Web has been present in Japan since 2004, the developer calls the sale of security products for Unix systems his main achievement.

When entering the Japanese market, the developer will apply the "Switch to Green" migration program. It provides users of other antiviruses with a 50% discount when switching to a one-year Dr.Web license.

2011

Doctor Web, a Russian funds developer information security , announced the move and expansion of its representative office in. France The new office will be based in Strasbourg (Alsace region). Its tasks include the development of product sales Dr.Web throughout the West, Europe the Dr.Web said in a statement. As explained in the company, the foundation of a representative office in Strasbourg is of important strategic importance: Dr.Web gets the opportunity to directly enter the European markets for information security tools. The new office has its own user support service (including technical support) and a team of experienced sales managers ON Dr.Web. Thanks to this, Dr.Web expects to strengthen the position of the Dr.Web brand in. To Europe

2015

The share of Dr.Web revenues from license sales to corporate users exceeded 63%

Doctor Web announced that in 2015 the share of revenues from sales of licenses for Dr.Web products to the corporate segment of customers continued to grow and amounted to 63.8%, almost 10% higher than the same figure in 2014. Small, medium and large businesses remain the main group of users of domestic antivirus.

According to the company, over the past five years, the share of sales of Dr.Web licenses for business has grown steadily, having crossed the 50% milestone in 2013, and today it accounts for almost two-thirds of the total sales flow.

The main corporate solution of the company is the Dr.Web Enterprise Security Suite, which includes information security tools for any object - from workstations to mobile devices. In 2015, sales of Dr.Web Desktop Security Suite workstation security products grew by 12.46%, Dr.Web Server Security Suite server products by 12.84%, Dr.Web Mail Security Suite email filtering products by 8.76%, and Dr.Web Gateway Security Suite internet gateway protection products by 21.55%.

According to the developers, among the features of the company's products are the presence of a single Management Center for easy administration, the ability to protect mobile devices, the availability of licenses and certificates of regulatory authorities, which allow, among other things, to ensure the security of systems that contain personal data or high-level information secrecy.

Sanctions in Ukraine

On September 16, 2015, President of Ukraine Petro Poroshenko signed an addendum to the decree banning public procurement from several dozen companies, including the Russian Kaspersky Lab and Dr.Web.

These companies are prohibited from selling their products to state institutions and enterprises in Ukraine, since these decisions, as Poroshenko's decree suggests, pose a potential threat to the country's national security and contribute to terrorist activities. Read more here.

Slyki

Online reseller RussianKey